Skip to main content
. 2023 May 22;24(10):9104. doi: 10.3390/ijms24109104

Figure 7.

Figure 7

Two-dimensional and three-dimensional binding interaction diagrams of 12 and erlotinib within active site of BRAFV600E (BRAFm; PDB ID: 3OG7).